Esta guía sirve para reforzar la importancia de la calidad de los servicios de vacunación y para ofrecer una dirección renovada al diseño, la entrega y la evaluación de servicios de...
Estas recomendaciones provisionales1 se refieren a la vacuna mRNA-1273, fabricada por Moderna, que también se conoce como vacuna anti-COVID-19 de Moderna. En algunos países la vacuna se...
Recomendaciones provisionales para el uso de la vacuna de Valneva (VLA2001) contra la COVID-19: orientaciones provisionales, versión inicial: 18 de agosto de 2022
Recomendaciones provisionales sobre el uso de la vacuna BNT162b2 de Pfizer y BioNTech contra la COVID-19 en el marco de la Lista OMS de uso en emergencias: orientaciones provisionales, primera...
Organización Panamericana de la Salud (OPS), World Health Organization (WHO)
Bolivia: Análisis de la respuesta de los países a la COVID-19, identificando las mejores prácticas y las brechas cruciales a tener en cuenta en los planes de respuesta futuros,Bolivia: Análisis...
This document is includes information on WHO position on pneumococcal vaccines in infants in children; vaccine characteristics; safety; PCV performance; programmatic considerations; cost and...
The Global Health Expenditure Database (GHED) provides comparable data on health expenditure for 192 countries over the past 20 years. Health spending indicators are key guides for monitoring...
COSTVAC is an Excel-based toolkit that provides structured guidance on how to estimate the cost of routine immunization from a sample of health facilities and administrative levels of the health...
Human resources – the health workers who actually deliver health services – are the most costly and least readily available resource in a health system. They are also indispensable. Managers at...
UNIVAC is a single universal vaccine impact and cost-effectiveness decision support model with a standardized, accessible Excel-based (now based in R), interface and a familiar set of input steps and...
Contenido: En esta presentación se resumen las recomendaciones y consideraciones más recientes de la OMS para elegir productos vacunales contra la COVID-19 con la lista de la OMS para uso de...
This guidance is focused on establishing and managing a UCC system. It provides practical guidance to support countries in planning and selecting the appropriate UCC system design and equipment based...
¿Cuánto más estamos dispuestos a pagar por una vacuna que pueda utilizarse fuera de la cadena de frío? ¿Merece la pena pagar más por una vacuna calificada como CTC? ¿Cómo y cuándo es la CTC...
Esfuerzo de equipo de protección personal (EPP) de los trabadores de salud comunotarios (CHW) en Liberia: lecciones aprendidas sobre cómo tratar de obtener visibilidad y uso de datos durante una...
Los sistemas de gestión de datos son fundamentales para proporcionar visibilidad a los datos logísticos de extremo a extremo, pero sólo si "hablan" entre sí. Durante esta sesión, exploraremos...
Alex de Jonquieres, Ann Lindstrand, Benjamin Schreiber, Marie Khémesse Ngom Ndiaye, Robin Nandy, Saada Al Salti, Souleymane Kone
El primer día de la 16ª Conferencia TechNet se abre con un enfoque en las estrategias de la cadena de suministro de inmunización y la respuesta de Covid-19.
Dado que COVID exige tamaños de sesión más pequeños, es más importante que nunca considerar un tamaño de vial de vacuna más pequeño para adaptarse mejor a los tamaños de las sesiones.Esta...
Adama Sawadogo, Claude Mangobo, Oleg Benes, Serge Ganivet, Souleymane Kone
En esta sesión se investigarán las formas en que los programas nacionales de inmunización pueden llegar a determinados grupos objetivo de la vacuna Covid-19, como los trabajadores sanitarios y los...
La pandemia de COVID-19 ha proporcionado a los países los retos pero también las oportunidades de innovar para coordinar mejor las cadenas de suministro de inmunización nacionales y subnacionales...
Thomas Sorensen, Michelle Seidel, Karuna Luthra, Jalia Nanfuka
Gavi y UNICEF: Novedades de CCEOP (Plataforma de optimización de equipos de cadena de frío), IMPT (Herramienta de mantenimiento de inteligencia y adquisición) y adquisiciones
La prestación de servicios de alta calidad y centrados en las personas es fundamental para aumentar la aceptación y la aceptación de la inmunización. Mediante ejemplos ilustrativos, exploramos...
Boly Diop, Cindy Chiu de Vázquez, Sidat Fofana, Sonam Wangchuk
Aprenda las experiencias de los países en la implementación de la vacuna contra la COVID-19 y el cómo la están evaluando utilizando la revisión intra-acción (IAR) de la inmunización contra la...
Luis Andres De Francisco, Margherita Ghiselli, Martha Velandia, Nathalie Vande Maele, Ulla Griffiths
Este primer seminario web de una serie ofrecerá una introducción al nuevo enfoque y a las orientaciones disponibles. La sesión se tradujo al español, portugués y francés (esta grabación está...
Charu Garg, Eric Laurent, Saurabh Agarwal, Ulla Griffiths
NIS.COST es un nuevo enfoque desarrollado por UNICEF para estimar los costes y las implicaciones presupuestarias de la aplicación de una Estrategia Nacional de Inmunización de cinco años. La...
Nathalie Vande Maele, Ulla Griffiths, Eric Laurent
Este primer seminario web de una serie ofrecerá una introducción al nuevo enfoque y a las orientaciones disponibles. La sesión se tradujo al español, portugués y francés (esta grabación está...
The purpose of this document is two-fold. The first is to provide criteria for selecting technologies to facilitate decision making for
improved health care waste management in health care...
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the...
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries...
The meningitis road map has been designated as a flagship global strategy of the WHO’s Thirteenth General Programme of Work, 2019–2023 and is an essential component in achieving universal health...
La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du...
Following new vaccine introduction into a routine immunization programme, the purpose of a post-introduction vaccine evaluation (PIE) is to evaluate the impact of the vaccine introduction on the...
This document is essential and timely to help countries ensure that all COVID-19 vaccine doses are optimally utilized, and wastage is minimised. Due to the short shelf-life, several countries have...
Guidance on conducting vaccine effectiveness evaluations in the setting of new SARS-CoV-2 variants: Interim guidance, 22 July 2021. Addendum to Evaluation of COVID-19 vaccine effectiveness
This resource explains how WHO EUL COVID-19 vaccines without vaccine vial monitor or VVM should be handled at the vaccination site, to ensure that safe and potent vaccines are administered.
Fernando Torres, Paula Domínguez, M Eugenia Aruanno, M Julia Macherett, Eliana S Nocent, Lucía Risoli, Magdalena Sasso, Carmen Cabello, María N Seoane
Introduction: The reduction in the number of visits to health care centers since the onset of the SARS-CoV-2 pandemic may affect mandatory vaccination.
Objective: To assess the impact of the...
In multi-dose vials, there can be a difference between the number of doses stated on the vaccine label and the true number of doses that can be withdrawn. The true number of doses available from a...
The CVIC tool provides a structured and comprehensive estimation of incremental operational and selected capital costs of introducing and deploying COVID-19 vaccines, in alignment with the National...
The WHO Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR) was developed to guide countries to conduct periodic review(s) of their national and subnational COVID-19 response, so...
The COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) is a non-replicating adenoviral vector vaccine against coronavirus disease 2019 (COVID-19). The vector virus contained within the vaccine...
This brief summarizes a comprehensive review and assessment of current, published evidence for a single-dose HPV vaccination schedule. The review was undertaken by researchers in the Single-Dose HPV...
A synthesis of the full review on current, published evidence relevant to single-dose HPV vaccination. This includes immunogenicity, efficacy and effectiveness; identification of gaps in the...
These WHO interim recommendations on the use of the mRNA-1273 vaccine (Moderna) against COVID-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on...
Given the urgency and wide-ranging effects of the COVID-19 pandemic, SAGE has developed an approach to help inform deliberation around the range of recommendations that may be appropriate under...
The ACT-Accelerator was set up to contain the COVID-19 pandemic faster and more efficiently by ensuring that successful diagnostics, vaccines and treatments are shared equitably across all...
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vector vaccine against coronavirus disease 2019 (COVID-19). The vaccine expresses the SARS-CoV-2 spike protein gene,...
This manual is designed to assist the countries of the Region of the Americas in planning the operational components of the immunization program to ready them for the COVID-19 vaccine. To accomplish...
COMIRNATY® is a messenger RNA (mRNA) based vaccine against coronavirus disease 2019 (COVID-19). The mRNA instructs the cell to produce proteins of the S antigen (a piece of the spike protein unique...
A planning tool for national programme managers to conduct multi-year needs-forecasting for vaccines, safe injection supplies, storage and transport facilities. For national or intermediate...
World Health Organization (WHO), United Nations Children's Fund (UNICEF)
Interim guidance 12 February 2021. This document provides guidance for countries to: develop and strengthen supply chain strategies to receive, store, distribute and manage COVID-19 vaccines and...
There are few interventions targeting young adolescents and those that do exist are often not adequately reaching them. This is because the number of contacts between the health system and...
In accordance with its mandate to provide
guidance to Member States on health policy matters, WHO issues a series of regularly updated position papers on vaccines
and combinations of vaccines...
In accordance with its mandate to provide
guidance to Member States on health
policy matters, WHO issues a series of
regularly updated position papers
on vaccines and combinations of...
National governments require economic data on the burden of influenza disease, the cost effectiveness of the vaccine, and the projected implementation costs of a maternal influenza immunization...
WHO has developed an introduction manual for national immunization programme managers and policy-makers to support the introduction of health worker influenza immunization.
En el contexto de la Pandemia COVID-19, el sistema de salud se enfrenta a un incremento rápido de la demanda, que podría llevarlo a un colapso, tanto por la morbilidad y mortalidad directa por el...
Value-based procurement (VBP) is the practice of evaluating potential new products, services, and solutions to maximize overall value for money (VFM), rather than focusing only on the lowest purchase...
Objective: Provide guidance regarding the operation of immunization programs in the context of the COVID-19 pandemic.
This publication updates the previous publication from 26 March 2020.
A key part of this 73rd World Health Assembly landmark resolution was that as well as fighting COVID-19, governments need to also ensure that essential health services are maintained. One of the most...
This document:
I. outlines a common framework for decision-making for the conduct of preventive and outbreak response
campaigns;
II. offers principles to consider when deliberating the...
Go.Data is a collaborative project coordinated by WHO and conducted in cooperation with partners of the Global Outbreak Alert and Response Network (GOARN). The Go.Data tool is available globally to...
Screening areas, treatment centres and community facilities are part of the strategic priorities for Severe Acute Respiratory Infection (SARI) outbreak preparedness, readiness and response. The SARI...
These FAQs accompany WHO’s Guiding principles for immunization activities during the COVID-19 pandemic.1
As the COVID-19 pandemic evolves, these FAQ will be revised as necessary,
Immunizations...
The economical chemical indicators can be started individually by pulling out the start strip. They measure only one or max. 2 temperature limits per indicator and are available for the following...
Para mejorar los resultados de la inmunización es esencial contar con datos oportunos y de alta calidad. La revisión de IDEA es una síntesis global de la evidencia existente que ayuda a construir...
Para mejorar los resultados de la inmunización es esencial contar con datos oportunos y de alta calidad. La revisión de IDEA es una síntesis global de la evidencia existente que ayuda a construir...
Para mejorar los resultados de la inmunización es esencial contar con datos oportunos y de alta calidad. La revisión de IDEA es una síntesis global de la evidencia existente que ayuda a construir...